[1] Bakker K, Apelqvist J, Lipsky BA, et al. The 2015 IWGDF
guidance documents on prevention and management
of foot problems in diabetes: development of an evidencebased
global consensus [J]. Diabetes Metab Res Rev, 2016,
32(Suppl 1):2-6.
[2] 中华医学会糖尿病学分会. 中国2 型糖尿病防治指南(2013 年版)
[J].中华内分泌代谢杂志,2014,30(10):893-942.
[3] Wagner FW. The dysvascular foot: a system for diagnosis
and treatment [J]. Foot Ankle, 1981,2(2):64-122.
[4] 黄清霞.512 例糖尿病足患者流行病学及截肢危险因素的回顾性
研究[D].汕头大学,2014.
[5] 王爱红,赵湜,李强,等. 中国部分省市糖尿病足调查及医学经济
学分析[J].中华内分泌代谢杂志,2005,21(6):496-499.
[6] Ekere AU, Yellowe BE, Bob- Yellowe E, et al. Pattern
and management approach of diabetic foot disease in a developing
country [J]. Niger J Med, 2005,14(3):272-275.
[7] Danmusa UM, Terhile I, Nasir IA, et al. Prevalence and
healthcare costs associated with the management of diabetic
foot ulcer in patients attending Ahmadu Bello University
Teaching Hospital, Nigeria [J]. Int J Health Sci (Qassim),
2016,10(2):219-228.
[8] 常宝成,曾淑范.208 例糖尿病足流行病学及临床特点分析[J]. 中
华糖尿病杂志,2005(2):129-130.
[9] Pemayun TG, Naibaho RM, Novitasari D, et al. Risk factors
for lower extremity amputation in patients with diabetic
foot ulcers: a hospital-based case-control study [J]. Diabet
Foot Ankle, 2015,6:29629.
[10] 洪静,朱虹,吴文俊,等.570例糖尿病足病患者住院费用及影响因
素分析[J].中华医院管理杂志,2014,10(10):755-759.